Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Overview
- Status
-
Private
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) General Information
Description
A portfolio of royalties on future sales of approved drugs. The portfolio consists of rights to receive royalties on the future sales of pharmaceutical drugs under the brand names Movantik, Adynovate, and Rebinyn.
Contact Information
Corporate Office
- San Francisco, CA
- United States
Corporate Office
- San Francisco, CA
- United States
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) FAQs
-
Where is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) headquartered?
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is headquartered in San Francisco, CA.
-
What industry is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) in?
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s primary industry is Buildings and Property.
-
Is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) a private or public company?
Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is a Private company.
-
What is the current valuation of Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)?
The current valuation of Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is .
-
What is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s current revenue?
The current revenue for Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is .
-
Who are Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s investors?
HCRx has invested in Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process